September 23, 2017 8:01 AM ET


Company Overview of Bodisen Biotech Inc.

Company Overview

Bodisen Biotech, Inc. develops, manufactures, and sells organic and liquid fertilizers, pesticides, and insecticides in the People’s Republic of China. The company sells its products through a network of regional distributors. Bodisen Biotech, Inc. is based in Xi’an, the People’s Republic of China.

Fanmei Building

Room 2001

No. 1 NaguanZhengjie

Xian,  710068


132 Employees


86 29 8707 4957

Key Executives for Bodisen Biotech Inc.

Chairman, Chief Executive Officer and President
Age: 49
Founder, Executive Director, Director of BBST and Director of Yang Ling
Age: 56
Chief Financial Officer and Principal Accounting Officer
Age: 43
Chief Operating Officer
Age: 42
Age: 49
Compensation as of Fiscal Year 2017.

Bodisen Biotech Inc. Key Developments

Bodisen Biotech, Inc. Deleted From Other OTC

Bodisen Biotech, Inc.’s common stock deleted from Other OTC, effective August 26, 2016. The deletion was due to revocation of registration by SEC under section 12(j).

SEC Orders Hearings On Registration Suspension Or Revocation Against Bodisen Biotech For Failure To Make Required Periodic Filings

Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of Bodisen Biotech Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Bodisen Biotech Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at